Publications: Dr Hiro Farabi
Farabi H, Moradi N, Ahmadzadeh A, Agamir SMK, Mohammadi A, Rezapour A
(
2023
)
.
Factor associated with willingness to pay for prevention of cancer: a study of prostate cancer screening
.
Cost Effectiveness and Resource Allocation
vol.
21
,
(
1
)
Mohammadi A, Farabi H, Baghdadabad LZ, Narouie B, Reis LO, Aghamir SMK
(
2023
)
.
Serum and 24-hour urinary tests cost-effectiveness in stone formers
.
BMC Urology
vol.
23
,
(
1
)
Arabshahi SKS, Nikjoo S, Rezapour A, Kemmak AR, Jahangiri R, Farabi H, Barghazan SH
(
2022
)
.
Economic Evaluation of Palliative Care for Patients with Cancer Disease: A Systematic Review
.
Medical Journal of the Islamic Republic of Iran
vol.
36
,
Nargesi S, Dolatshahi Z, Rezapour A, Alipour V, Souresrafil A, Farabi H, Javadmoosavi SA, Safakhah M et al.
(
2021
)
.
Cost-effectiveness of osimertinib in the treatment of advanced EGFR-mutated non-small cell lung cancer: a systematic review
.
Expert Review of Pharmacoeconomics & Outcomes Research
vol.
22
,
(
4
)
543
-
554
.
Meshkani Z, Zarei L, Hajimoladarvish N, Arabloo J, Rezapour A, Farabi H, Moradi N
(
2021
)
.
Private Demand for Covid-19 Vaccine: A Contingent Assessment from a Low-and Middle-income Country
.
Iranian Journal of Pharmaceutical Research
vol.
20
,
(
3
)
223
-
234
.
Kemmak AR, Rezapour A, Jahangiri R, Nikjoo S, Farabi H, Soleimanpour S
(
2020
)
.
Economic burden of osteoporosis in the world: A systematic review
.
Medical Journal of the Islamic Republic of Iran
vol.
34
,
154
-
154
.